December 25, 2014 6:21 PM ET

Biotechnology

Company Overview of Genzyme Corporation

Executive Profile

Peter Wirth Esq., J.D.

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 6 different industries.

See Board Relationships
63--

Background

Mr. Peter Wirth, Esq., JD, is the Founder of Lysosomal Therapeutics Inc. Mr. Wirth's areas of legal expertise include venture capital financings, institutional private placements, public offerings, off-balance sheet R&D financings such as RDLPs and SWORDS, corporate collaborations, joint ventures and mergers and acquisitions. Mr. Wirth served as the Chief Legal Officer and Executive Vice President of Corporate Development & Legal of Genzyme Oncology, Inc. (also known ...

Corporate Headquarters

500 Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-252-7500
Fax: 617-252-7600

Board Members Memberships

2001-N/A
Former Director, Chairman of Audit Committee and Member of Nominating and Governance Committee
2012-Present
Director, Member of Audit Committee and Member of Compensation Committee
2012-Present
Chairman of The Board

Education

JD 1975
Harvard Law School
BA 1972
Concordia University, Wisconsin

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genzyme Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.